Viral Vector Manufacturing Market
Viral vector manufacturing refers to the production of a carrier called
a vector which is genetically engineered to deliver the gene because they can
deliver the new gene by infecting the cell. Considered as a drug
substance, viral vectors are used in gene therapy and vaccinology (vaccines).
In the case of cell therapies, the scrutiny for testing for adventitious agents
is high.
Viruses that are often used as vectors include retroviruses that
integrate their genetic material including the new gene in the human cell, and
adenoviruses, that introduce their DNA into the nucleus of the cell without
letting the DNA to integrate into a chromosome. These viruses are modified so
they can't cause disease when used in people.
Gene therapy has seen various clinical advancement, and along with it,
the viral vector manufacturing market is growing pervasively. Gene therapy is
one of the most preferred treatment options for a number of chronic diseases.
Over the past few years, the viral vector manufacturing market is growing
rapidly mainly due to the growing prevalence of devastating neurodegenerative
diseases including Parkinson’s, Alzheimer’s, and ALS.
Global Viral
Vector Manufacturing Market Size is expected to register a CAGR
20.20% with an expected market value of USD 678.70 million during the forecast
period
The increasing number of clinical trials and the growing necessity for
an effective mode of disease treatment are some of the factors fostering the
growth of the market. Additional factors having a synergistic effect on the
growth of the viral vector manufacturing market include the increasing number
of technological advancements, a growing number of ambulatory services, and government
initiatives.
On the flip side, factors such as the high cost of gene therapies and
possible mutagenesis alongside the strict government regulation and
time-consuming approval process are expected to impede market growth.
Major Key
Players:
Key Viral Vector Manufacturing Market
Players are Sanofi, Lonza, FUJIFILM Diosynth
Biotechnologies U.S.A., Inc., Merck KGaA, General Electric Company, uniQure
N.V., Oxford BioMedica, Spark Therapeutics, Inc., FinVector Vision Therapies,
Cobra Biologics, Brammer Bio, Cell and Gene Therapy Catapult, REGENXBIO Inc.,
and Kaneka Eurogentec S.A. among others.
Segment Analysis
The MRFR analysis is segmented into five key dynamics
for enhanced understanding.
By Type: Retroviral
Vectors, Adeno-Associated Viral Vectors, and Adenoviral Vectors among others.
By Disease: Cancer,
Genetic Disorders and Infectious Diseases among others.
By Application: Gene Therapy and Vaccinology among others.
By End-user :
Pharmaceutical Companies, Biotechnology Companies, and Research Institutes,
among others.
By Regions: Asia
Pacific, North America, Europe, and the Rest-of-the-World.
Regional Analysis
Global Viral Vector
Manufacturing Market Insights, based on region, has been divided
into Europe, the Americas, Asia-Pacific, and Middle East & Africa.
The North American Region heading
with the growing prevalence of autoimmune and chronic diseases, accounts for
the leading market for viral vector production, globally. Moreover, technological advancements in the
manufacturing of these vectors is a key force driving the growth of this
market.
Additionally, favorable
reimbursement policies and the presence of well-developed healthcare
infrastructure, and increasing geriatric population are some of the key driving
forces contributing to the growth of the regional market.
The U.S., backed by a large
number of patients suffering from Alzheimer’s and Parkinson's diseases, majorly
contributes to an increase in the demand for viral vectors in the region.
Moreover, factors such as the high healthcare expenditures alongside the
availability of viruses required for the production of these vectors and
technological expertise drive the growth of the regional market.
The European region, led by the
well-established R&D sector accounts for the second-largest market for viral
vector manufacturing. Besides, factors such as the availability of funds
for research and increasing healthcare expenditures drive the regional market.
Moreover, the increase in occurrences of chronic diseases has led to the rise
in the market growth in the region. Also, the presence of a developed
healthcare sector and the resurging economy in the region foster the growth of
the viral vector manufacturing market in Europe.
The viral vector manufacturing
market in the Asia Pacific region is emerging as a promising market owing to
the huge patient population suffering from diseases such as Parkinson’s,
Alzheimer’s, and ALS.
Moreover, continuously growing
healthcare sector led by the rapid economic growth in the APAC that is
increasing the per capita healthcare expenses is a dominant driving force
behind the growth of the regional market. Recent economic data suggests that
China along with Southeast Asia is expected to join the ranks of the
deep-pocketed Asian economies such as Taiwan and Korea.
China, owing to the presence of a
huge geriatric population leads the viral vector manufacturing market in the
APAC. Whereas, India due to the vast population base, rapidly changing economy,
and the increasing number of manufacturers of these vectors, accounts for the
second largest market in the region.
Whereas, the Middle East &
Africa (MEA)region has the least market share due to the lack of awareness and
low healthcare expenditures. The viral vector manufacturing market in the MEA
region will exhibit moderate growth during the corresponding period.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
